Regulation of EBV Latency by Purine Metabolism and Signaling
通过嘌呤代谢和信号传导调节 EBV 潜伏期
基本信息
- 批准号:10611467
- 负责人:
- 金额:$ 45.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-19 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqATRX geneAdenineAdenosineAdenosine KinaseAnabolismB Cell ProliferationB lymphocyte immortalizationB-LymphocytesCellsCellular biologyChIP-seqChromatinChromatin ModelingChromosomesComplexDAXX geneDNA BindingDataDeaminaseEBV-associated diseaseEnzymesEpigenetic ProcessEpstein-Barr Virus InfectionsEpstein-Barr Virus Nuclear AntigensEpstein-Barr Virus latencyEpstein-Barr Virus-Related Malignant NeoplasmEventG-Protein-Coupled ReceptorsGene ExpressionGenesGenomeHistone H3.3Human Herpesvirus 4Human Herpesvirus 8ImmuneImmune signalingInflammatoryLinkLymphomagenesisLytic VirusMalignant NeoplasmsMass Spectrum AnalysisMetabolicMetabolic ControlMetabolismMolecular ChaperonesNuclearPathway interactionsPlayPrimary InfectionProcessProteinsPurinesPurinoceptorRegulationRoleSignal TransductionTestingTherapeutic InterventionTranscriptional ActivationTranscriptional RegulationViralViral GenesViral PhysiologyVirusVirus DiseasesVirus Latencycell transformationgammaherpesvirushelicaseinhibitormetabolomicsmouse modelnew therapeutic targetnovelprogramspurine metabolismselective expressiontranscriptional reprogrammingtranscriptome sequencingtumortumorigenesisvirus related cancer
项目摘要
Epstein-Barr Virus (EBV) reprograms host cell gene expression and metabolism during the establishment of latency and the immortalization of B-lymphocytes. The regulatory mechanisms coordinating this reprogramming with EBV latency reflect important events in viral oncogenesis, yet remain poorly understood. We have found that key viral regulators of EBV latency, including the major tegument protein BNRF1 and the EBV Nuclear Antigen EBNA1 coordinate key aspects of purine metabolism during establishment of latency and immortalization of primary B-cells. In this R01, we focus on how EBV reprograms purine metabolic gene expression, and how purine metabolites contribute directly to EBV tumorigenesis. One clue to this coordinate regulation is provided by the viral-encoded tegument protein BNRF1 that shares extensive structural similarity to the purine biosynthetic enzyme FGARAT (also called PFAS) and functions in viral chromatin assembly during primary infection. Orthologues of BNRF1 are found in all gamma herpesviruses, including KSHV ORF75, and share the common function of disarming components of the PML-nuclear body (PML-NB) and its anti-viral functions. We have previously shown that BNRF1 interacts with the histone H3.3 chaperone DAXX and displaces its interaction with the ATP-dependent SNF2-like helicase ATRX to enable selective expression of latency-specific viral genes during primary infection. However, it has not yet been shown how the viral FGARAT homology domain is linked to cellular purine biosynthesis and/or signaling. Using metabolomics mass spectrometry, we provide new preliminary data indicating that the purine biosynthetic pathway is among the most significantly perturbed by EBV during B-cell immortalization. Integrating gene expression (RNA-Seq), chromatin accessibility (ATAC-Seq), and EBNA1-DNA binding to host chromosome (ChIP-Seq), we identified cellular metabolic genes, including adenine deaminase (ADA), adenosine kinase 4 (AK4), and purinergic receptors P2RY8 and P2RX5 as direct targets of EBNA1 transcriptional regulation during EBV immortalization. We now propose to investigate the mechanisms by which EBV senses and reprograms purine metabolism and how purinergic signaling regulates establishment of EBV latency and host cell transformation. We will test the central hypothesis that EBV coordinately regulates cellular purine metabolism with viral and cellular gene expression during the B-cell immortalization process, and that purinergic signaling is critical for viral latency and oncogenesis. Specifically, we will investigate how EBV regulates expression of purine metabolic genes during primary infection (Aim 1), elucidate how purine metabolism impacts the establishment of EBV latency (Aim 2), and investigate the role of purine metabolism and signaling in B-cell immortalization, immune signaling, and EBV-induced tumorigenesis (Aim 3). These studies will advance our understanding of basic mechanisms coordinating gene expression with metabolism and identify new targets for therapeutic intervention in viral latency and viral-associated cancers.
EB病毒(EBV)在B淋巴细胞的潜伏期和永生化的建立期间重编程宿主细胞基因表达和代谢。调节机制协调这种重编程与EBV潜伏期反映了病毒肿瘤发生中的重要事件,但仍然知之甚少。我们已经发现,EBV潜伏期的关键病毒调节因子,包括主要的被膜蛋白BNRF 1和EBV核抗原EBNA 1,在原代B细胞的潜伏期和永生化的建立期间协调嘌呤代谢的关键方面。在R 01中,我们关注EBV如何重编程嘌呤代谢基因表达,以及嘌呤代谢产物如何直接促进EBV肿瘤发生。这种协调调节的一个线索是由病毒编码的被膜蛋白BNRF 1提供的,该蛋白与嘌呤生物合成酶FGARAT(也称为PFAS)具有广泛的结构相似性,并在原发感染期间在病毒染色质组装中发挥作用。BNRF 1的直系同源物存在于所有γ疱疹病毒中,包括KSHV ORF 75,并且共享解除PML核体(PML-NB)的组分的共同功能及其抗病毒功能。我们以前已经表明,BNRF 1与组蛋白H3.3分子伴侣DAXX相互作用,并取代其与ATP依赖性SNF 2样解旋酶ATRX的相互作用,使潜伏期特异性病毒基因的选择性表达在原发感染。然而,尚未显示病毒FGARAT同源结构域如何与细胞嘌呤生物合成和/或信号传导连接。使用代谢组学质谱,我们提供了新的初步数据表明,嘌呤生物合成途径是最显着的干扰EB病毒在B细胞永生化。整合基因表达(RNA-Seq)、染色质可及性(ATAC-Seq)和EBNA 1-DNA与宿主染色体的结合(ChIP-Seq),我们鉴定了细胞代谢基因,包括腺嘌呤脱氨酶(ADA)、腺苷激酶4(AK 4)和嘌呤能受体P2 RY 8和P2 RX5,作为EBV永生化过程中EBNA 1转录调控的直接靶标。我们现在建议调查的机制,EB病毒的感觉和重新编程嘌呤代谢和嘌呤信号如何调节EB病毒潜伏期和宿主细胞转化的建立。我们将测试的核心假设,EBV协调调节细胞嘌呤代谢与病毒和细胞的基因表达在B细胞永生化过程中,嘌呤能信号是病毒潜伏期和肿瘤发生的关键。具体而言,我们将研究EBV如何调节嘌呤代谢基因在原发性感染过程中的表达(目标1),阐明嘌呤代谢如何影响EBV潜伏期的建立(目标2),并研究嘌呤代谢和信号传导在B细胞永生化,免疫信号传导和EBV诱导的肿瘤发生中的作用(目标3)。这些研究将促进我们对基因表达与代谢协调的基本机制的理解,并确定病毒潜伏期和病毒相关癌症治疗干预的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Italo Tempera其他文献
Italo Tempera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Italo Tempera', 18)}}的其他基金
PARP1-Chromatin and NAD-Metabolism in EBV Epithelial Cancers
EBV 上皮癌中的 PARP1-染色质和 NAD-代谢
- 批准号:
10627691 - 财政年份:2023
- 资助金额:
$ 45.76万 - 项目类别:
Regulation of Viral Chromatin Architecture During EBV Latency
EBV 潜伏期病毒染色质结构的调节
- 批准号:
10219524 - 财政年份:2018
- 资助金额:
$ 45.76万 - 项目类别:
Regulation of Viral Chromatin Architecture During EBV Latency
EBV 潜伏期病毒染色质结构的调节
- 批准号:
10249367 - 财政年份:2018
- 资助金额:
$ 45.76万 - 项目类别:
Regulation of Viral Chromatin Architecture During EBV Latency
EBV 潜伏期病毒染色质结构的调控
- 批准号:
10372232 - 财政年份:2018
- 资助金额:
$ 45.76万 - 项目类别:
Role of Nuclear Lamina in the epigenetic regulation of Epstein-Barr Virus Infection
核层在 Epstein-Barr 病毒感染的表观遗传调控中的作用
- 批准号:
9293955 - 财政年份:2016
- 资助金额:
$ 45.76万 - 项目类别:
Regulation of EBV Latency by Chromosome Conformation
染色体构象对 EBV 潜伏期的调节
- 批准号:
8593390 - 财政年份:2013
- 资助金额:
$ 45.76万 - 项目类别:
相似海外基金
Molecular pathological mechanisms of the brain development disorder using the chromatin-remodeling molecule ATRX gene knockout mouse
染色质重塑分子ATRX基因敲除小鼠脑发育障碍的分子病理机制
- 批准号:
23300147 - 财政年份:2011
- 资助金额:
$ 45.76万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of the Zn finger domain encoded by the ATRX gene whose mutations result in X-linked alpha thalassemia mental retardation(ATR-X) syndrome
ATRX基因编码的锌指结构域的功能分析,其突变导致X连锁α地中海贫血精神发育迟滞(ATR-X)综合征
- 批准号:
18570170 - 财政年份:2006
- 资助金额:
$ 45.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Y CHROMOSOME MODEL FOR THE SEX DETERMINING FUNCTION OF THE HUMAN ATRX GENE
人类 ATRX 基因性别决定功能的 Y 染色体模型
- 批准号:
nhmrc : 148630 - 财政年份:2001
- 资助金额:
$ 45.76万 - 项目类别:
NHMRC Project Grants
Investigation of the role of the ATRX gene in normal mammalian development
ATRX 基因在正常哺乳动物发育中的作用研究
- 批准号:
nhmrc : 987013 - 财政年份:1998
- 资助金额:
$ 45.76万 - 项目类别:
Early Career Fellowships